Corvus Pharmaceuticals, Inc. (CRVS) Operating Lease, Right-of-Use Asset USD 2018 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Corvus Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from 2018 to 2024.
  • Corvus Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2024 was $865 K, a 55.7% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $865 K -$1.09 M -55.7% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $1.15 M -$1.07 M -48.2% Dec 31, 2023 10-Q 2024-05-07
Q3 2023 $1.42 M -$1.04 M -42.3% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $1.69 M -$1.02 M -37.6% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $1.95 M -$999 K -33.8% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $2.22 M -$973 K -30.5% Dec 31, 2022 10-K 2024-03-19
Q3 2022 $2.47 M -$953 K -27.9% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $2.71 M +$1.45 M +115% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $2.95 M +$1.5 M +103% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $3.19 M +$1.54 M +93.6% Dec 31, 2021 10-K 2023-03-28
Q3 2021 $3.42 M +$1.6 M +87.4% Sep 30, 2021 10-Q 2021-11-01
Q2 2021 $1.26 M -$732 K -36.7% Jun 30, 2021 10-Q 2021-08-02
Q1 2021 $1.46 M -$708 K -32.7% Mar 31, 2021 10-Q 2021-04-29
Q4 2020 $1.65 M -$679 K -29.2% Dec 31, 2020 10-K 2022-03-10
Q3 2020 $1.83 M -$658 K -26.5% Sep 30, 2020 10-Q 2020-10-29
Q2 2020 $2 M -$638 K -24.2% Jun 30, 2020 10-Q 2020-07-30
Q1 2020 $2.16 M -$618 K -22.2% Mar 31, 2020 10-Q 2020-04-30
Q4 2019 $2.33 M +$2.33 M Dec 31, 2019 10-K 2021-03-25
Q3 2019 $2.48 M Sep 30, 2019 10-Q 2019-10-30
Q2 2019 $2.63 M Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $2.78 M Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $0 Dec 31, 2018 10-K 2020-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.